Voraxaze

Active Ingredient(s): Glucarpidase
FDA Approved: * January 17, 2012
Pharm Company: * BTG INTERNATIONAL INC
Category: Antidotes

A carboxypeptidase (EC number 3.4.16 - 3.4.18) is a protease enzyme that hydrolyzes (cleaves) a peptide bond at the carboxy-terminal (C-terminal) end of a protein or peptide. This is in contrast to an aminopeptidases, which cleave peptide bonds at the N-terminus of proteins. Humans, animals, bacteria and plants contain several types of carboxypeptidases that have diverse functions ranging from catabolism to protein maturation. Contents 1 Mechanism 2 Functions 3 Classifications 3.1 By activ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Voraxaze 1000 [usp'u]/1 Intravenous Injection, Powder, for Solution
NDC: 50633-210
Labeler:
Btg International Inc.